Refining the Atopic March: Mechanisms of Progression in Black and White Children
Refining the Atopic March: Mechanisms of Progression in Black and White Children
批准号:
10260727
负责人:
Gurjit K. Khurana Hershey
金额:
$54.68万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
未结题
起止时间:
2006-07-01 至 2026-06-30
关键词:
AffectAgeAge FactorsAge of OnsetAllergensAllergicAllergic DiseaseAllergic inflammationAllergic rhinitisAsthmaAtopic DermatitisBiodiversityBiologicalBiological FactorsBlack raceBloodChildChildhood AsthmaClinicalClinical DataComplexDataDevelopmentDiseaseDisease ProgressionDisease remissionEducational workshopEnvironmental Risk FactorEpithelialFlow CytometryFoodFood HypersensitivityGene ExpressionGenesGeneticHeterogeneityHypersensitivityImmuneImmunologicsImmunophenotypingLaboratoriesLengthLifeLiteratureLongitudinal StudiesLongitudinal cohortMelaninsMethodsMorbidity - disease rateMutationNatural HistoryOrganOutcomeParticipantPathogenesisPathway interactionsPatient Self-ReportPatternPhenotypePopulationPrevalenceProxyPublic HealthRaceResearchResolutionRespiratory Signs and SymptomsRiskRisk FactorsSeveritiesSex FactorsSkinSocioeconomic FactorsSubgroupTimeTranscendUnited States National Institutes of Healthbasecohortcomorbiditydesigneditorialfilaggringenome-widehealth disparitymast cellmortalityperipheral bloodprospectiveracial biasracial differenceskin microbiomesocial culturesocioeconomicstranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
For nearly two decades, the “atopic march” concept, which describes the sequential development of atopic
dermatitis (AD), food allergy (FA), asthma, and allergic rhinitis (AR) has served as a guiding principle, however,
a recent NIH workshop concluded that only about 3% of children follow the traditional atopic march. They stated
that while early-life AD remains a major risk factor for the development of any atopic disease, there is no single
unique pathway for the atopic march. Rather, there is significant heterogeneity including the timing and organ(s)
affected, and the march needs to be revised to include this heterogeneity and incorporate the various
combinations. We designed the Mechanisms of Progression of Atopic Dermatitis (AD) to Asthma in CHildren
(MPAACH) cohort, the first US prospective longitudinal early life cohort of AD, to meet this need. MPAACH
includes 65% Black children and is one of the only early life cohorts that represents this historically
underrepresented and understudied population. Previous studies of the atopic march were done mostly in White
populations. Our early findings from MPAACH reveal marked racial differences in the atopic march concept and
underscore the racial bias in current paradigms around the atopic march. Black children are disproportionately
impacted by asthma prevalence, morbidity, and mortality and this race-asthma association is not eliminated after
adjusting for socioeconomic factors
suggesting that race may also serve as a proxy for a critical biologic factor
that we do not currently recognize. Our central hypothesis is that the longitudinal trajectories of sensitization and
allergic disease progression are different between Whites and Blacks, and that this is mechanistically due, in
part, to biologic differences. We will conduct skin transcriptomics and integrate this data with longitudinal
immunologic, environmental, and clinical data to construct the pathogenesis of allergic disease development,
progression, persistence, remission, and resolution. Race is a complex concept including sociocultural and
socioeconomic, as well as biologic factors. As such, we will define Black and White using self-reported race,
genetic ancestry, and biologic methods that quantify melanin content in the skin, thus recognizing the continuum
resulting from biologic diversity in addition to the sociocultural definitions of race. This application will have
significant public health impact. Through the proposed aims, we will (1) define longitudinal AD phenotypes in
Black and White MPAACH children, (2) elucidate skin transcriptomic profiles and biologic pathways that predict
AD longitudinal phenotypes for Black and White MPAACH children and (3) define longitudinal
immunophenotypes of AD in Black and White children and construct the pathogenesis of allergic disease by race
based on genetics (from Project 2)--> skin transcriptomics--> immunologic milieu--> longitudinal clinical
endotypes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Medical Scientist Training Program
-
批准号:10620999
-
项目类别:
-
资助金额:$92.89万
-
财政年份:2023
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Multi-omics of the Frequent Exacerbator Asthmatic
-
批准号:10197294
-
项目类别:
-
资助金额:$45.2万
-
财政年份:2021
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Multi-omics of the Frequent Exacerbator Asthmatic
-
批准号:10596089
-
项目类别:
-
资助金额:$45.2万
-
财政年份:2021
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Multi-omics of the Frequent Exacerbator Asthmatic
-
批准号:10390405
-
项目类别:
-
资助金额:$45.2万
-
财政年份:2021
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Atopic dermatitis: mechanisms of disease progression
-
批准号:10379962
-
项目类别:
-
资助金额:$53.91万
-
财政年份:2020
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Atopic dermatitis: mechanisms of disease progression
-
批准号:10596577
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2020
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Atopic dermatitis: mechanisms of disease progression
-
批准号:9974832
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2020
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Role and Regulation of TSLP in Childhood Allergic Disease
-
批准号:10307538
-
项目类别:
-
资助金额:$73.07万
-
财政年份:2017
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Role and Regulation of TSLP in Childhood Allergic Disease
-
批准号:10063471
-
项目类别:
-
资助金额:$74.72万
-
财政年份:2017
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Infrastructure and Opportunity Fund Management
-
批准号:8329216
-
项目类别:
-
资助金额:$14.41万
-
财政年份:2011
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Administrative Core
-
批准号:8196249
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2011
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Genetics of epithelial genes in childhood asthma
-
批准号:8196244
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2011
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Biology of IL-13 receptor Alpha-2 in Asthma
-
批准号:7929959
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2009
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Epithelial Genes In Allergic Inflammation
-
批准号:7898208
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2009
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Development of an Asthma Research Core Center
-
批准号:7936176
-
项目类别:
-
资助金额:$44.57万
-
财政年份:2009
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Impact of Early Life Diesel Exposure on Immune Patterning and Lung Structure/Func
-
批准号:7924049
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2009
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Impact of Early Life Diesel Exposure on Immune Patterning and Lung Structure/Func
-
批准号:7714257
-
项目类别:
-
资助金额:$54.11万
-
财政年份:2009
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Impact of Early Life Diesel Exposure Immune Patterning & Lung Structure/Function
-
批准号:8306191
-
项目类别:
-
资助金额:$49.83万
-
财政年份:2009
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Development of an Asthma Research Core Center
-
批准号:7860750
-
项目类别:
-
资助金额:$54.88万
-
财政年份:2009
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
Impact of Early Life Diesel Exposure on Immune Patterning and Lung Structure/Func
-
批准号:8107575
-
项目类别:
-
资助金额:$51.57万
-
财政年份:2009
-
负责人:Gurjit K. Khurana Hershey
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: